2024-11-012025-10-312025-10-31falseSC077232RICCARTON NURSERIES LIMITED2026-07-31falseiso4217:GBPxbrli:pureSC0772322024-10-31SC0772322025-10-31SC0772322024-11-012025-10-31SC0772322023-10-31SC0772322024-10-31SC0772322023-11-012024-10-31SC077232bus:SmallEntities2024-11-012025-10-31SC077232bus:AuditExempt-NoAccountantsReport2024-11-012025-10-31SC077232bus:AbridgedAccounts2024-11-012025-10-31SC077232bus:PrivateLimitedCompanyLtd2024-11-012025-10-31SC077232core:WithinOneYear2025-10-31SC077232core:AfterOneYear2025-10-31SC077232core:WithinOneYear2024-10-31SC077232core:AfterOneYear2024-10-31SC077232core:ShareCapital2025-10-31SC077232core:SharePremium2025-10-31SC077232core:RevaluationReserve2025-10-31SC077232core:OtherReservesSubtotal2025-10-31SC077232core:RetainedEarningsAccumulatedLosses2025-10-31SC077232core:ShareCapital2024-10-31SC077232core:SharePremium2024-10-31SC077232core:RevaluationReserve2024-10-31SC077232core:OtherReservesSubtotal2024-10-31SC077232core:RetainedEarningsAccumulatedLosses2024-10-31SC077232core:LandBuildings2025-10-31SC077232core:PlantMachinery2025-10-31SC077232core:Vehicles2025-10-31SC077232core:FurnitureFittings2025-10-31SC077232core:OfficeEquipment2025-10-31SC077232core:NetGoodwill2025-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2025-10-31SC077232core:ListedExchangeTraded2025-10-31SC077232core:UnlistedNon-exchangeTraded2025-10-31SC077232core:LandBuildings2024-10-31SC077232core:PlantMachinery2024-10-31SC077232core:Vehicles2024-10-31SC077232core:FurnitureFittings2024-10-31SC077232core:OfficeEquipment2024-10-31SC077232core:NetGoodwill2024-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2024-10-31SC077232core:ListedExchangeTraded2024-10-31SC077232core:UnlistedNon-exchangeTraded2024-10-31SC077232core:LandBuildings2024-11-012025-10-31SC077232core:PlantMachinery2024-11-012025-10-31SC077232core:Vehicles2024-11-012025-10-31SC077232core:FurnitureFittings2024-11-012025-10-31SC077232core:OfficeEquipment2024-11-012025-10-31SC077232core:NetGoodwill2024-11-012025-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-31SC077232core:ListedExchangeTraded2024-11-012025-10-31SC077232core:UnlistedNon-exchangeTraded2024-11-012025-10-31SC077232core:MoreThanFiveYears2024-11-012025-10-31SC077232core:Non-currentFinancialInstruments2025-10-31SC077232core:Non-currentFinancialInstruments2024-10-31SC077232dpl:CostSales2024-11-012025-10-31SC077232dpl:DistributionCosts2024-11-012025-10-31SC077232core:LandBuildings2024-11-012025-10-31SC077232core:PlantMachinery2024-11-012025-10-31SC077232core:Vehicles2024-11-012025-10-31SC077232core:FurnitureFittings2024-11-012025-10-31SC077232core:OfficeEquipment2024-11-012025-10-31SC077232dpl:AdministrativeExpenses2024-11-012025-10-31SC077232core:NetGoodwill2024-11-012025-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-31SC077232dpl:GroupUndertakings2024-11-012025-10-31SC077232dpl:ParticipatingInterests2024-11-012025-10-31SC077232dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-31SC077232core:ListedExchangeTraded2024-11-012025-10-31SC077232dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-31SC077232core:UnlistedNon-exchangeTraded2024-11-012025-10-31SC077232dpl:CostSales2023-11-012024-10-31SC077232dpl:DistributionCosts2023-11-012024-10-31SC077232core:LandBuildings2023-11-012024-10-31SC077232core:PlantMachinery2023-11-012024-10-31SC077232core:Vehicles2023-11-012024-10-31SC077232core:FurnitureFittings2023-11-012024-10-31SC077232core:OfficeEquipment2023-11-012024-10-31SC077232dpl:AdministrativeExpenses2023-11-012024-10-31SC077232core:NetGoodwill2023-11-012024-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-31SC077232dpl:GroupUndertakings2023-11-012024-10-31SC077232dpl:ParticipatingInterests2023-11-012024-10-31SC077232dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-31SC077232core:ListedExchangeTraded2023-11-012024-10-31SC077232dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-31SC077232core:UnlistedNon-exchangeTraded2023-11-012024-10-31SC077232core:NetGoodwill2025-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2025-10-31SC077232core:LandBuildings2025-10-31SC077232core:PlantMachinery2025-10-31SC077232core:Vehicles2025-10-31SC077232core:FurnitureFittings2025-10-31SC077232core:OfficeEquipment2025-10-31SC077232core:AfterOneYear2025-10-31SC077232core:WithinOneYear2025-10-31SC077232core:ListedExchangeTraded2025-10-31SC077232core:UnlistedNon-exchangeTraded2025-10-31SC077232core:ShareCapital2025-10-31SC077232core:SharePremium2025-10-31SC077232core:RevaluationReserve2025-10-31SC077232core:OtherReservesSubtotal2025-10-31SC077232core:RetainedEarningsAccumulatedLosses2025-10-31SC077232core:NetGoodwill2024-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2024-10-31SC077232core:LandBuildings2024-10-31SC077232core:PlantMachinery2024-10-31SC077232core:Vehicles2024-10-31SC077232core:FurnitureFittings2024-10-31SC077232core:OfficeEquipment2024-10-31SC077232core:AfterOneYear2024-10-31SC077232core:WithinOneYear2024-10-31SC077232core:ListedExchangeTraded2024-10-31SC077232core:UnlistedNon-exchangeTraded2024-10-31SC077232core:ShareCapital2024-10-31SC077232core:SharePremium2024-10-31SC077232core:RevaluationReserve2024-10-31SC077232core:OtherReservesSubtotal2024-10-31SC077232core:RetainedEarningsAccumulatedLosses2024-10-31SC077232core:NetGoodwill2023-10-31SC077232core:IntangibleAssetsOtherThanGoodwill2023-10-31SC077232core:LandBuildings2023-10-31SC077232core:PlantMachinery2023-10-31SC077232core:Vehicles2023-10-31SC077232core:FurnitureFittings2023-10-31SC077232core:OfficeEquipment2023-10-31SC077232core:AfterOneYear2023-10-31SC077232core:WithinOneYear2023-10-31SC077232core:ListedExchangeTraded2023-10-31SC077232core:UnlistedNon-exchangeTraded2023-10-31SC077232core:ShareCapital2023-10-31SC077232core:SharePremium2023-10-31SC077232core:RevaluationReserve2023-10-31SC077232core:OtherReservesSubtotal2023-10-31SC077232core:RetainedEarningsAccumulatedLosses2023-10-31SC077232core:AfterOneYear2024-11-012025-10-31SC077232core:WithinOneYear2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-31SC077232core:Non-currentFinancialInstrumentscore:CostValuation2025-10-31SC077232core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-31SC077232core:Non-currentFinancialInstrumentscore:CostValuation2024-10-31SC077232core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-31SC077232core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-31SC077232bus:Director12024-11-012025-10-31

RICCARTON NURSERIES LIMITED

Registered Number
SC077232
(Scotland)

Unaudited Financial Statements for the Year ended
31 October 2025

RICCARTON NURSERIES LIMITED
Company Information
for the year from 1 November 2024 to 31 October 2025

Director

MUNRO, Sidonie Anne Elisabeth

Company Secretary

CROCKETT, James Hay

Registered Address

82 Riccarton Mains Road
Currie
EH14 5AA

Registered Number

SC077232 (Scotland)
RICCARTON NURSERIES LIMITED
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets346,62657,955
Investments410,00210,002
56,62867,957
Current assets
Stocks101,375122,375
Debtors5129,94382,069
Cash at bank and on hand35,00747,007
266,325251,451
Creditors amounts falling due within one year6(64,679)(68,433)
Net current assets (liabilities)201,646183,018
Total assets less current liabilities258,274250,975
Creditors amounts falling due after one year7(11,481)(19,697)
Net assets246,793231,278
Capital and reserves
Called up share capital31,55731,557
Profit and loss account215,236199,721
Shareholders' funds246,793231,278
The financial statements were approved and authorised for issue by the Director on 31 July 2026, and are signed on its behalf by:
MUNRO, Sidonie Anne Elisabeth
Director
Registered Company No. SC077232
RICCARTON NURSERIES LIMITED
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20252024
Average number of employees during the year1717
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 November 24212,298
At 31 October 25212,298
Depreciation and impairment
At 01 November 24154,343
Charge for year11,329
At 31 October 25165,671
Net book value
At 31 October 2546,626
At 31 October 2457,955
At the year-end, the Net Book Value of assets under HP was £23,357 (2024: £29,196).
4.Fixed asset investments

Total

£
Cost or valuation
At 01 November 2410,002
At 31 October 2510,002
Net book value
At 31 October 2510,002
At 31 October 2410,002
5.Debtors: amounts due within one year

2025

2024

££
Other debtors129,94377,379
Prepayments and accrued income-4,690
Total129,94382,069
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables31,26830,005
Bank borrowings and overdrafts2,9165,000
Taxation and social security5,4114,596
Finance lease and HP contracts5,2995,299
Other creditors18,09922,048
Accrued liabilities and deferred income1,6861,485
Total64,67968,433
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts-2,917
Other creditors11,48116,780
Total11,48119,697
8.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts16,78022,079
9.Directors advances, credits and guarantees
At the year-end, there was a balance due to the Director from Riccarton Nurseries Ltd of £178 (2024: £195). This loan is interest-free and is repayable on demand.
10.Related party transactions
At the year-end there is a balance of £118,567 (2024: £64,410) due from R Munro of Fife Limited, a company in which S Munro is also a director.
11.Controlling party
The ultimate controlling party is Mrs. S Munro.